Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020)
XSHE XSHE Primary Summary
002020 Chart
People also search for
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Zhejiang Jingxin Pharmaceutical Co., Ltd. ever had a stock split?
Zhejiang Jingxin Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Lv Gang CEO | XSHE Exchange | CNE000001K73 ISIN |
| CN Country | 3,869 Employees | 11 Jun 2026 Last Dividend | 23 May 2016 Last Split | 29 Jun 2004 IPO Date |
Overview
Zhejiang Jingxin Pharmaceutical Co., Ltd. is a multifaceted pharmaceutical company with a vigorous presence in both the Chinese market and the international arena. Founded in 1990, initially known as Zhejiang Jingxin Pharmaceutical Factory, the company underwent a notable rebranding in 2000 to its current identity. Since its inception, it has been at the forefront of pharmaceutical research and development, manufacturing, and sales. With its headquarters in Xinchang, China, Jingxin Pharmaceutical has carved out a significant niche in the pharmaceutical and medical device sectors by focusing on a diverse range of therapeutic areas and continuously expanding its product portfolio.
Products and Services
Pharmaceutical Products
Jingxin Pharmaceutical offers a variety of medical products aimed at addressing multiple health conditions:
- Antihypertensive: Medications designed to manage and lower high blood pressure, contributing to cardiovascular health.
- Antibiotics and Quinolones: Broad-spectrum antibiotics, including ciprofloxacin and levofloxacin, used to treat a wide range of bacterial infections.
- Gastrointestinal Promotion: Treatments that aid in the digestion process, improving gastrointestinal health.
- Antidiabetic: Medications like empagliflozin and dapagliflozin for managing diabetes.
- Antiepileptic: Drugs such as levetiracetam and brivaracetam for controlling seizures in epilepsy.
- Antihistamine and H+ Pump Depressant: For allergy relief and reducing stomach acid production, respectively.
- Antihypercholesterolemia: Agents like simvastatin and rosuvastatin calcium to lower cholesterol levels.
- Antidepressant: Medications such as sertraline HCI for treating depression.
- Cephalosporins and Biopharma Products: A class of antibiotics and various biopharmaceuticals targeting different health issues.
API Products
Jingxin Pharmaceutical also specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) for use in various medications, including:
- Ciprofloxacin and Levofloxacin Series: Key ingredients for quinolone antibiotics.
- Simvastatin, Rosuvastatin Calcium, and Pitavastatin Calcium: Essential components for cholesterol-lowering drugs.
- Ticagrelor, Rivaroxaban, Apixaban: APIs for anticoagulant medications used to prevent blood clots.
- Empagliflozin and Dapagliflozin: Components for antidiabetic drugs.
Medical Display Products
In addition to pharmaceuticals, the company has ventured into the production of medical display technology:
- Diagnostic Medical Displays: High-resolution screens for medical diagnostics.
- Surgical Medical Displays: Displays designed for use in surgical environments, providing critical visual information.
- Clinical Medical Displays: Utilized throughout clinical settings for various purposes, including patient monitoring.
- Medical Large Screens and Integrated Machines: For broader applications in healthcare facilities, enhancing the visibility and management of medical data.
- Ultrasonic Medical Displays: Specialized screens for displaying ultrasonic images during medical examinations.
